Compare FSP & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FSP | STXS |
|---|---|---|
| Founded | 1981 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.4M | 210.0M |
| IPO Year | N/A | 2004 |
| Metric | FSP | STXS |
|---|---|---|
| Price | $0.89 | $2.60 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 476.8K | ★ 556.5K |
| Earning Date | 02-10-2026 | 11-11-2025 |
| Dividend Yield | ★ 4.39% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $109,497,000.00 | $30,075,000.00 |
| Revenue This Year | $4.36 | $24.21 |
| Revenue Next Year | $0.81 | $29.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 19.62 |
| 52 Week Low | $0.85 | $1.54 |
| 52 Week High | $2.09 | $3.59 |
| Indicator | FSP | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 38.87 | 62.79 |
| Support Level | $0.87 | $2.25 |
| Resistance Level | $0.95 | $2.77 |
| Average True Range (ATR) | 0.05 | 0.11 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 25.43 | 72.94 |
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.